Related Experiment Video
Updated: Jun 3, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Clinical development directions in oncolytic viral therapy
1Mary Crowley Cancer Research Centers, Dallas, TX 75201, USA.
Cancer Gene Therapy
|March 26, 2011
Summary
Oncolytic virotherapy uses engineered viruses to selectively destroy cancer cells. This emerging cancer treatment shows safety and clinical responses, especially in resistant tumors.
Area of Science:
- Oncology
- Virology
- Biotechnology
Background:
- Oncolytic virotherapy is an emerging experimental treatment for cancer.
- Oncolytic viruses are engineered to replicate selectively in cancer cells.
- Various DNA and RNA viruses have undergone clinical testing across diverse tumor types.
Purpose of the Study:
- To review novel anticancer biologics used in oncolytic virotherapy.
- To summarize clinical investigation results of oncolytic virotherapy.
- To highlight the potential and challenges of this therapeutic approach.
Main Methods:
- Review of clinical investigations involving oncolytic viruses.
- Analysis of safety and efficacy data from clinical trials.
- Identification of challenges in maximizing therapeutic efficacy and delivery.
Main Results:
- Oncolytic virotherapy has demonstrated a favorable safety profile.
- Clinical responses have been observed in tumors resistant to conventional therapies.
- The approach shows promise as a novel cancer treatment modality.
Conclusions:
- Oncolytic virotherapy is a safe and promising cancer treatment.
- Further research is needed to enhance efficacy and systemic delivery.
- Maximizing the potential of viral therapeutics remains a key objective.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...